1,106 material Form 8-K filings that 909 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Eversource Energy said it completed the sale of Aquarion Water Company to Aquarion Water Authority, a Connecticut public entity, for $2.4 billion in cash. The company expects an after-tax non-cash charge of about $115 million, or $0.31 per share, in the second quarter of 2026, and it revised its 2026 non-GAAP EPS guidance to $4.57 to $4.72 per share, which excludes Aquarion earnings going forward.
Total purchase price was $2.4 billion in cash; adjusted net equity proceeds of about $1.7 billion will be used to pay down Eversource debt.
After-tax non-cash charge of about $115 million, or $0.31 per share, expected in Q2 2026.
Revised 2026 non-GAAP guidance is $4.57 to $4.72 per share; the prior base-year midpoint cited is $4.65 per share.
Sale was approved by the Connecticut Public Utilities Regulatory Authority on March 25, 2026, after a definitive agreement signed January 27, 2025.
ArrowMark Financial Corp. (BANX) said its Chief Financial Officer, Patrick Farrell, retired and that Katherine Jones, 41, was appointed CFO effective June 30, 2026. President Dana Staggs also resigned, and the company's press release gives an August 2, 2026 effective date for her departure. The filing reports no financial results, and the changes affect shareholders mainly through the company's leadership and governance.
Katherine Jones, 41, appointed Chief Financial Officer effective June 30, 2026; the 8-K says she is not expected to receive compensation for the role
Patrick Farrell retired as Chief Financial Officer effective June 30, 2026
Dana Staggs resigned as President; the 8-K gives June 30, 2026, while the press release gives August 2, 2026
Chairman and CEO Sanjai Bhonsle said Staggs's duties will be assumed by several investment team members
Subsidiaries of Lumexa Imaging Holdings, Inc. amended their existing credit agreement on June 30, 2026, providing a secured term loan of approximately $823 million and a secured $250 million revolving credit line. The filing describes new restrictive covenants, a leverage test that applies if revolver usage exceeds 40%, and guarantees and collateral pledged by most subsidiaries, which shareholders should weigh as added debt and lender constraints.
Replacement term loan of approximately $823 million matures in December 2032, priced at SOFR plus 2.50% or Prime plus 1.50%.
Revolving credit facility of $250 million matures in December 2030, with pricing at SOFR plus 2.50% or Prime plus 1.50%, subject to reduction on certain leverage ratios.
If revolver exposure exceeds 40% of the facility at quarter-end, the consolidated net leverage ratio must not exceed 7.50 to 1.
Barclays Bank PLC is administrative agent; the loans are guaranteed and secured by substantially all wholly-owned subsidiaries' assets, subject to exceptions.
On June 22, 2026, SolarMax Technology received a Nasdaq notice that it does not meet the Nasdaq Capital Market requirement to maintain at least $35 million in market value of listed securities. The company has 180 calendar days, until December 21, 2026, to regain compliance, and this notice is in addition to an earlier Nasdaq notice about its $1.00 minimum bid price. If the company does not regain compliance by then, it will receive written notice that its securities are subject to delisting.
Nasdaq notice dated June 22, 2026, cites Rule 5550(b)(2), the $35 million minimum market value of listed securities.
Compliance period runs 180 calendar days and expires December 21, 2026.
Regaining compliance requires market value of at least $35 million for a minimum of ten consecutive business days.
Separate from the previously announced Nasdaq notice for failing the $1.00 minimum bid price.
REalloys Inc. said Chief Financial Officer Robert Winspear resigned effective June 24, 2026, and the board named Craig Cunningham as his successor the same day, through a consulting agreement with Provenance Advisors Inc. A director, Joseph Sawyer, also resigned effective June 29, 2026, and the board does not plan to fill that seat. The CFO change and the consulting-based pay package are the main items for shareholders to note.
Robert Winspear's CFO separation agreement provides a $200,000 lump-sum severance payment, 20,000 fully vested restricted shares, and a tax-related cash payment.
Craig Cunningham, age 43, was appointed CFO effective June 24, 2026, under a 24-month consulting agreement with Provenance Advisors at $55,000 per month.
Cunningham's initial long-term incentive award has a target grant-date value of $990,000.
Director Joseph Sawyer resigned effective June 29, 2026; the board does not intend to fill the vacancy.
Patrick Industries agreed to acquire LCI Industries in an all-stock merger in which LCI shareholders receive 1.2440 Patrick shares for each LCI share. After closing, Patrick holders would own about 52% of the combined company and LCI holders about 48%, and the company is expected to close in the first half of 2027, subject to shareholder and regulatory approvals.
Exchange ratio: 1.2440 Patrick common shares for each LCI common share, plus cash in lieu of fractional shares
Ownership after closing: about 52% Patrick shareholders and 48% LCI shareholders
Companies cite more than $150 million of estimated run-rate cost synergies, to be achieved within three years of closing
Outside Date for the Mergers is March 30, 2027, with two three-month extensions possible for regulatory conditions; Andy Nemeth remains CEO and Todd Cleveland is named Chair
Spire Inc. completed the sale of its Spire Storage businesses, which hold natural gas storage assets in Wyoming and Oklahoma, to an affiliate of I Squared Capital on June 30, 2026. The 8-K gives total consideration of $657 million, while the accompanying press release states $650 million, so the figures differ slightly. Spire says the proceeds will support its regulated utility operations, capital plan and debt reduction, and help fund its earlier Piedmont Natural Gas Tennessee acquisition.
Total consideration is $657 million in the 8-K: $607 million cash at closing, subject to price adjustments, plus $50 million deferred until September 30, 2027.
The press release states $650 million total ($600 million cash at closing plus a $50 million deferred payment in fiscal 2027).
Proceeds help fund the Piedmont Natural Gas Tennessee acquisition, which closed March 31, 2026.
The storage business will operate as Bear River Midstream LLC under I Squared; the Wyoming assets can provide up to 55 Bcf of working gas capacity and the Oklahoma facility up to 17 Bcf.
Seadrill Finance Limited, a wholly owned subsidiary of Seadrill Limited, issued $700 million of 6.750% senior notes due 2034 on June 30, 2026. The company used part of the proceeds to deposit funds that fully cover the redemption of its remaining 8.375% senior secured second lien notes due 2030, discharging that indenture, and it also reported an amended revolving credit facility that increased commitments from $225 million to $300 million, effective June 30, 2026 and undrawn to date.
$700 million of 6.750% senior notes issued June 30, 2026, maturing July 15, 2034
Proceeds deposited to redeem all outstanding 8.375% 2030 notes, of which about $575 million was outstanding as of March 31, 2026
Revolving credit facility commitments increased from $225 million to $300 million, effective June 30, 2026, with no draws to date
Notes callable on or after July 15, 2029 at 103.375% in 2029 and 101.688% in 2030
Papa John's Chief Financial Officer and President, North America Ravi Thanawala is leaving effective June 30, 2026 to become CFO at another public company, and Chris Collins has been named interim CFO while the company searches for a permanent replacement. The filing states the resignation was not due to any disagreement with the company, and Thanawala will advise through July 31, 2026, with no severance entitlement.
Ravi Thanawala resigns as CFO and President, North America, effective June 30, 2026; advisory role through July 31, 2026
Christopher K. Collins, 56, SVP of Corporate Finance and Principal Accounting Officer, appointed interim CFO effective June 30, 2026
Collins' base salary raised to $415,000 and target bonus set at 75% of base salary while he serves as interim CFO
Marc Richard, SVP of North America Operations, takes over all North America operations; second quarter results due August 6, 2026
Fox Corporation entered a $1.0 billion senior unsecured term loan credit agreement on June 30, 2026, with Morgan Stanley Senior Funding as administrative agent. The lenders' commitment is contingent on the Roku acquisition closing, and proceeds will pay part of the cash consideration and related amounts, adding debt that shareholders will need to track against the deal's terms.
Facility size: $1.0 billion senior unsecured term loan, with the ability to incur up to $1.0 billion of additional term loans subject to conditions
Funding is contingent on consummation of the Roku, Inc. acquisition, announced June 15, 2026
Loans mature two years after the acquisition closes and funds; the company must maintain an operating income leverage ratio of 4.5 to 1.0
Commitment fees on unused commitments begin accruing October 12, 2026
Talos Energy and an affiliate of Ridgewood Energy agreed on June 30, 2026 to buy oil and gas properties in the Gulf of America from Shell Offshore for an unadjusted $1.7 billion, with Talos's share at $850 million. Talos expects its final net cash consideration to be about $450 million to $500 million, and it plans to fund the deal with cash on hand and debt, which shareholders should weigh against the added production and reserves and the closing uncertainty.
Talos's share of the unadjusted purchase price is $850 million, with a $42.5 million deposit already in escrow and credited at closing.
Acquired assets include about 23 MMBoe of proved reserves, 10 MMBoe of probable reserves, and first quarter 2026 average production of about 16 MBoe/d (about 77% oil).
BP has a 30-day preferential right on the Na Kika interests; if exercised, Talos would acquire only the Coulomb field interest.
The credit agreement amendment raises the borrowing base from $700 million to $850 million ($800 million if BP exercises its right), effective upon closing, and the deal is expected to close by the end of 2026.
Lattice Semiconductor entered a Second Amended and Restated Credit Agreement with Wells Fargo as administrative agent, providing a $200.0 million senior secured revolver and a $950.0 million senior secured delayed draw term loan. No amounts were outstanding at closing, and the term loan may be used to help pay the cash purchase price for the previously announced AMI acquisition. The facility adds debt that is secured by substantially all of the company's and guarantors' assets and must be repaid in quarterly installments after any draw.
Revolving loan of $200.0 million, usable for working capital and general corporate purposes, with commitments and loans due June 30, 2031; no revolving loans outstanding at closing.
Delayed draw term loan of $950.0 million for the AMI acquisition and related fees and expenses; no term loans outstanding at closing, and the commitment ends November 9, 2026 if not used earlier.
Borrowings bear interest at SOFR plus a margin of 1.00% to 1.75%, or a base rate option, with a 0.25% per annum ticking fee on undrawn term loan commitments.
Obligations are secured by substantially all assets and require compliance with total net leverage and interest coverage ratios tested quarterly.
Progress Software reported fiscal second-quarter 2026 revenue of $253 million, up 7% year over year, and GAAP diluted earnings per share of $0.50, up from $0.39. The company raised its fiscal 2026 revenue guidance to $990 million to $1.002 billion and its non-GAAP EPS guidance to $6.09 to $6.21, but lowered its GAAP EPS guidance to $1.60 to $1.74.
Q2 revenue was $253 million, up 7% year over year; ARR was $868 million, up 2% on a constant currency basis.
GAAP diluted EPS was $0.50 versus $0.39 a year earlier; non-GAAP diluted EPS was $1.62 versus $1.40.
FY2026 revenue guidance rose to $990 million to $1.002 billion from $988 million to $1 billion; non-GAAP EPS guidance rose to $6.09 to $6.21 from $5.91 to $6.03.
FY2026 GAAP diluted EPS guidance fell to $1.60 to $1.74 from $1.71 to $1.87 (prior guidance dated March 30, 2026).
LCI Industries and Patrick Industries signed a merger agreement on June 30, 2026 under which LCI would become a wholly owned subsidiary of Patrick, and LCI shareholders would receive 1.2440 Patrick shares for each LCI share. After closing, Patrick holders would own about 52% of the combined company and LCI holders about 48%, and the deal is expected to close in the first half of 2027, subject to shareholder, regulatory and other conditions.
Exchange ratio: 1.2440 shares of Patrick common stock for each LCI common share, plus cash in lieu of fractional shares
Ownership after closing: Patrick shareholders about 52%, LCI shareholders about 48%
The companies estimate more than $150 million of run-rate cost synergies, achieved within three years of closing
Outside Date for completion is March 30, 2027; expected closing is the first half of 2027
Air Products said it will exit its Louisiana Clean Energy Complex and its Casa Grande, Arizona green hydrogen project, along with other smaller clean energy projects. The company expects a pre-tax charge of up to $2.9 billion ($2.2 billion after tax) in its fiscal 2026 third quarter, which will weigh on reported results for shareholders.
Pre-tax charge of up to $2.9 billion, or $2.2 billion after tax, expected in fiscal 2026 third quarter
Cash expenditures related to the charges are estimated not to exceed $925 million, based on contractual terms
Louisiana exit followed a review; the company said expected returns did not meet its return criteria
Further charge details will be provided in the Form 10-Q for the period ending June 30, 2026
Pacira agreed on June 28, 2026 to sell its iovera handheld cryoanalgesia device business, including subsidiary Pacira CryoTech, to Zimmer, a subsidiary of Zimmer Biomet, for up to $140 million. The deal includes a $70 million upfront payment and up to $70 million in revenue-based milestone payments through December 31, 2031, and is expected to close in the third quarter of 2026. The company says it intends to use the upfront proceeds to strengthen its balance sheet, including paying down its senior secured revolving credit facility.
Upfront payment of $70.0 million, subject to customary adjustments for cash, receivables, indebtedness, transaction expenses and inventory
Milestone payments of $18.5 million, $23.5 million and $28.0 million if annual iovera net revenue reaches $50 million, $60 million or $70 million in any period from 2027 through 2031
66 employees expected to join Zimmer, about 8% of Pacira's total workforce
Purchase Agreement signed June 28, 2026; transaction expected to close in the third quarter of 2026
Angel Studios amended and restated its merger agreements to acquire Tuttle Twins Show, LLC (TTS) and Toothy Cow Productions, LLC (TCP), both signed November 14, 2025. The changes extend the outside date to October 31, 2026, and alter several closing conditions and the TCP merger structure. Company insiders and affiliates hold units in both companies and would receive Class A shares in the deals, and the company has already provided funding to both.
Outside date for both the TTS and TCP mergers extended to October 31, 2026
Closing condition requiring a showrunner agreement for Daniel Harmon removed from the TTS deal
Company related parties own 41.6% of TTS units and 2.4% of TCP units as of June 23, 2026
Company has provided $11.7 million to TTS and $11.9 million to TCP to date, with a maximum TCP funding commitment of $11.9 million
Rani Therapeutics appointed Nicholas M. Maestas as Chief Financial Officer, succeeding Svai Sanford, who had previously announced he would step down once a successor was named. The company also approved a 2026 Equity Inducement Plan reserving 5,500,000 Class A shares for new-hire awards, which does not require stockholder approval.
Maestas, age 46, was CFO and Head of Corporate Strategy at Tempest Therapeutics from January 2025 until June 2026.
Offer letter dated June 24, 2026 sets an annual base salary of $500,000 and a target bonus of 75% of base salary.
Maestas will receive a non-qualified option to purchase 2,000,000 Class A shares, vesting over four years.
The Board approved the Inducement Plan on June 28, 2026, reserving 5,500,000 shares.
On June 27, 2026, Martin Marietta agreed to acquire all equity interests in Lhoist North America from LNA Holding for $13.5 billion, consisting of $7 billion in cash and 10,953,543 newly issued Martin Marietta shares valued at $6.5 billion. After closing, LNA Holding is expected to hold about 15% of Martin Marietta's common stock, and the company has a $7.0 billion bridge loan commitment to fund the cash portion, so shareholders would face a larger share count and significant new borrowing if the deal closes.
Total consideration is $13.5 billion: $7 billion in cash plus 10,953,543 shares valued at $6.5 billion, based on the 15-day volume-weighted average price ending June 26, 2026
Closing requires expiration or termination of the Hart-Scott-Rodino waiting period and other regulatory approvals; long stop date is October 31, 2026, extendable to June 15, 2027
Martin Marietta would pay a $350 million termination fee if the deal ends under specified circumstances tied to failure to obtain regulatory clearances by the Extended Long Stop Date
A 364-day, $7.0 billion unsecured bridge facility from Goldman Sachs Bank USA and Goldman Sachs Lending Partners LLC is committed to finance the cash consideration
Four Corteva directors, Karen Grimes, Marcos Lutz, Charles Magro and Kerry Preete, agreed to resign from the Corteva board effective immediately before the planned spin-off of the seed business into Vylor, Inc. The filing says each is expected to join the Vylor board, and the resignations are not tied to any disagreement with the company. The companies also announced their post-separation boards, and the separation remains on track for the fourth quarter of 2026.
Resignations agreed June 26, 2026, and take effect only if the spin-off is completed
Greg Page to chair a nine-person Corteva board; Luke Kissam to join at separation
Karen Grimes to chair a seven-director Vylor board; a search is ongoing for at least one more member
Vylor filed its first Form 10 registration statement with the SEC; separation on track for 4Q 2026
TransAct Technologies appointed Troy W. Ingianni, formerly Vice President, Global Controller and Chief Accounting Officer at Barnes Group, as Chief Financial Officer, Secretary and Treasurer effective July 1, 2026, replacing Steven DeMartino, who retires from those roles June 30, 2026. The Board's earlier choice of Controller Robert Campbell for the role was withdrawn for personal reasons, and Mr. Ingianni also takes over as Principal Accounting Officer.
Ingianni's offer letter sets a base salary of $350,000 (prorated for 2026) and a target bonus of 35% of base salary.
He will receive 15,000 restricted stock units vesting in four equal annual installments.
Severance is six months' base salary for termination without cause, or 12 months' base salary following a change in control.
John M. Dillon, CEO, will also take the title of President upon DeMartino's retirement.
Midera Food Processing, a Middleby subsidiary, entered a five-year, $1.0 billion revolving credit agreement with Bank of America as administrative agent on June 29, 2026, in connection with its planned spin-off. The Borrower used borrowings and cash on hand to make a $233 million distribution to a Middleby subsidiary, and the spin-off is expected to take effect July 6, 2026, which means shareholders of Middleby will receive Midera shares and Midera will carry this new debt.
$1.0 billion facility: $750 million U.S. dollar revolver and $250 million multi-currency revolver, maturing June 29, 2031.
Before the spin-off takes effect, borrowings may not exceed $300 million; if the spin-off does not occur, commitments terminate within 15 business days.
The Borrower used borrowings and cash on hand to make a $233 million distribution to Middleby Marshall Inc., a Middleby subsidiary.
Middleby shareholders of record at 12:01 a.m. Eastern Time on July 6, 2026 are expected to receive Midera shares.
AeroVironment reported fiscal fourth-quarter 2026 revenue of $641.6 million, up 133% from $275.1 million, and net income of $63.2 million, or $1.25 per diluted share. For the full fiscal year, revenue rose 141% to $1,976.8 million, but the company posted a net loss of $265.1 million, or $5.40 per share, after a $240.7 million goodwill impairment. For fiscal 2027, the company expects revenue of $2.125 billion to $2.225 billion and net income of $8 million to $24 million.
Q4 fiscal 2026 revenue of $641.6 million; net income of $63.2 million, or $1.25 per diluted share, versus $16.7 million, or $0.59, a year earlier
Full-year fiscal 2026 net loss of $265.1 million, or $5.40 per diluted share, including a $240.7 million goodwill impairment
Fiscal 2027 guidance: revenue of $2.125 billion to $2.225 billion; net income of $8 million to $24 million; GAAP EPS of $0.16 to $0.48
Funded backlog of $1.2 billion as of April 30, 2026, versus $726.6 million a year earlier
Synchrony Financial announced executive leadership changes effective June 29, 2026. Carol Juel, formerly Executive Vice President, Chief Technology and Operating Officer, becomes Executive Vice President and Chief Executive Officer of the Digital platform, succeeding Bart Schaller, who plans to retire after a 35-year career. The company also promoted Florin Arghirescu to Chief Technology Officer and expanded DJ Casto's role to include Operations.
Carol Juel named EVP and CEO of the Digital platform, succeeding Bart Schaller, effective June 29, 2026
Florin Arghirescu promoted to EVP and Chief Technology Officer, reporting to CEO Brian Doubles
DJ Casto appointed EVP, Chief People and Operations Officer, adding servicing, collections and customer care to Human Resources
Copart's board appointed Executive Chairman A. Jayson Adair as chief executive effective July 31, 2026, replacing Jeffrey Liaw, who will also resign from the board. The filing discloses a transition agreement for Liaw with a $450,000 lump sum, $200,000 paid during a transition period through July 31, 2027, and additional conditional severance and equity benefits, which shareholders may weigh as part of the leadership change.
Adair, who previously led Copart as CEO, takes over on July 31, 2026, and Liaw steps down as CEO and director on the same date.
Liaw's transition agreement provides a $450,000 lump sum and $200,000 during the transition period, subject to a general release.
Liaw's conditional severance includes $250,000, accelerated vesting of remaining equity awards, and an extension of stock option exercise periods.
Adair is the son-in-law of Chairman Wills J. Johnson, a relationship the filing says is disclosed in the 2025 proxy statement.
Fortune Brands Innovations appointed Jesse Singh, former CEO of The AZEK Company, as chief executive and a board member, effective June 29, 2026. Interim CEO David Barry was named Executive Vice President and Chief Operating Officer, and the company has begun a strategic review of its Fiberon business.
Singh's base salary is $1,100,000, with a bonus target of 150% of salary and an annual long-term incentive target of $6,700,000.
Singh's inducement awards, granted July 1, 2026, cover 850,000 performance-based RSUs and a 300,000-share stock option award.
Barry receives a performance-based RSU award with a target grant value of $1,200,000 and a 25,000-share option award as COO.
Interim CFO Ashley George will remain in her role while the search for a permanent CFO continues.
SandRidge Energy's subsidiary signed a purchase agreement on June 26, 2026, to acquire oil and gas properties in the Cherokee Play from Rockies Resources Holdings LLC for $65 million in cash, plus three contingent earn-out payments of $2 million each. The company expects to fund the deal with cash on hand and close it in the third quarter of 2026, subject to customary closing conditions. The filing does not report financial results from the assets, so shareholders have no figures yet on how the deal will affect revenue or earnings.
Cash consideration of $65 million at closing, subject to customary purchase price adjustments
Three contingent earn-out payments of $2 million each, tied to WTI crude oil price thresholds from July 1, 2026 through December 31, 2027
Acquired assets include net production of about 3.0 MBoed (about 43% oil), about 7,000 net leasehold acres, interests in 21 wells and eight proven development locations
Expected closing in the third quarter of 2026; the press release says the effective date is May 1, 2026
JATT II Acquisition Corp., a blank check company, entered a business combination agreement with Talawar Tx Inc., a biotechnology developer of bispecific antibodies. The combined company is expected to trade on Nasdaq as TLWR and to receive up to $285 million before transaction costs, including a $225 million PIPE financing at $10.00 per share, if there are no redemptions by JATT II shareholders.
Business combination agreement signed June 29, 2026; JATT II shareholders must approve the deal, and closing is expected in the second half of 2026
Expected proceeds of $285 million before transaction costs, assuming no redemptions: $60 million from the JATT II trust account plus a $225 million PIPE
Combined company expected to trade on Nasdaq Capital Market under ticker TLWR; lead asset TALA-125 targets clinic entry in Q1 2027
Rocket Lab agreed on June 28, 2026 to acquire Iridium Communications in a cash and stock deal valued at $54 per Iridium share and an enterprise value of about $8.0 billion. Iridium holders would receive $27.00 in cash plus Rocket Lab stock, with the stock portion set by an exchange ratio that is subject to a collar between $67.50 and $112.50 per Rocket Lab share. The deal requires Iridium shareholder approval and regulatory clearances and is expected to close in mid-2027, and it is funded partly by a $3.6 billion bridge loan commitment.
Iridium holders receive $27.00 in cash plus Rocket Lab shares at an exchange ratio that is fixed at 0.4000 if the Rocket Lab price is $67.50 or below and at 0.2400 if it is $112.50 or above.
Iridium would pay Rocket Lab a $223.62 million termination fee in specified circumstances, including if its board withdraws support for the deal.
Rocket Lab has a 364-day senior secured bridge term loan commitment of $3.6 billion from Deutsche Bank and Wells Fargo.
The transaction is expected to close in mid-2027 and must be approved by a majority of Iridium's outstanding shares.
On June 28, 2026, Iridium agreed to merge with Rocket Lab, which will acquire all outstanding Iridium common stock for $27.00 in cash plus Rocket Lab shares per Iridium share. The companies put the notional value at $54.00 per share and the enterprise value at approximately $8.0 billion, and the deal requires an Iridium stockholder vote, antitrust clearance, and FCC consent. Iridium would owe Rocket Lab a $223.62 million termination fee in specified circumstances, and its shares would be delisted from Nasdaq if the deal closes.
Each Iridium share receives $27.00 in cash plus Rocket Lab stock; the exchange ratio is fixed at 0.4000 if the Rocket Lab price is $67.50 or less and at 0.2400 if it is $112.50 or more.
The transaction is expected to close in mid-2027, with an outside date of June 28, 2027, extendable to December 28, 2027.
Iridium would pay Rocket Lab a $223.62 million termination fee under specified circumstances, including if its board withdraws its recommendation.
Rocket Lab has received commitments for a $3.6 billion 364-day senior secured bridge term loan from Deutsche Bank and Wells Fargo.
BioCryst said its board approved on June 25, 2026 a plan to discontinue internal discovery programs and close its Birmingham, Alabama facility, with the work substantially complete by the end of 2026. The company cannot yet estimate the total cost of the plan and will file an amendment once it does, while lowering its 2026 non-GAAP operating expense guidance and reaffirming revenue guidance.
Board approved the plan on June 25, 2026; implementation expected to be substantially complete by the end of 2026.
Total costs of the plan are not yet estimated; expected costs include contract, lease and employee termination and severance.
2026 non-GAAP operating expense guidance lowered to $420 million to $440 million from $450 million to $470 million.
Total 2026 revenue guidance of $635 million to $660 million is reaffirmed; ORLADEYO oral pellets expected to be available in early August 2026.
Honeywell completed the spin-off of its Aerospace business effective 12:01 a.m. New York time on June 29, 2026, making Honeywell Aerospace Inc. an independent public company that began regular-way trading on Nasdaq that day. The 8-K also covers agreements with Honeywell on separation, transition services, taxes, employee matters, intellectual property and trademarks, and supplemental unaudited quarterly results for 2024 and 2025 showing full-year 2025 net sales up but net income attributable to the company down.
Distribution: one share of Honeywell Aerospace common stock for every two Honeywell common shares held at the close of business on June 15, 2026; fractional shares were sold and cash paid instead.
Trading began on Nasdaq under HONA on June 29, 2026, with CUSIP 43849R105. Honeywell continues as Honeywell Technologies.
FY 2025 net sales were $17,404 million versus $15,445 million in FY 2024, while net income attributable to Honeywell Aerospace was $2,687 million versus $2,817 million.
Genesco said Jonathan Collins will become Senior Vice President, Finance and Chief Financial Officer on August 3, 2026, and serve as principal financial officer from that date. Board Chair, President and CEO Mimi E. Vaughn, who has been interim CFO since March 2026, will stop serving in that role on the same date. The filing sets out Collins' pay package, which includes a $550,000 base salary and a $1,787,500 initial total direct compensation at target.
Collins' annual base salary is $550,000, with a Fiscal 2027 short-term incentive target of $412,500 and a long-term incentive target of $825,000.
Collins previously served as CFO of America's Car-Mart, Inc. from May 2025, and spent 2012 to 2025 at Walmart Inc., including as CFO of Walmart Africa.
Vaughn, who served as interim CFO since March 2026, will no longer be interim CFO or principal financial officer as of August 3, 2026.
Collins will receive a $25,000 quarterly relocation stipend, payable for three quarters.
Honeywell completed the spin-off of its Aerospace Technologies business, which now operates as Honeywell Aerospace (HONA), effective June 29, 2026. The parent now operates as Honeywell Technologies and continues to trade on Nasdaq as HON, and a 1-for-2 reverse stock split of its common stock took effect the same day. Shareholders should note the parent no longer consolidates Aerospace and that the share count was halved.
Spin-off effective 12:01 a.m. New York City time on June 29, 2026; Honeywell Aerospace began regular-way trading on Nasdaq as HONA that day.
Distribution ratio was one Aerospace share for every two Honeywell shares held at the close of business on the June 15, 2026 record date.
Reverse split reduced shares outstanding from about 634 million (March 31, 2026) to about 317 million; authorized shares cut from 2 billion to 1 billion.
Exhibit 99.2 recasts results: continuing-operations segment profit was $944 million in Q1 2026 versus $793 million in Q1 2025, and CEO James Currier resigned as an executive officer to lead Honeywell Aerospace.
Larimar Therapeutics said it has submitted the first module of a rolling Biologics License Application to the FDA for accelerated approval of nomlabofusp, after FDA meeting minutes said the existing data package appears sufficient for submission. The company also reported longer-term open label data, which showed improvements in some clinical measures alongside anaphylaxis in 10 of 43 patients, a safety finding shareholders should weigh.
First module of the rolling BLA submitted; remaining modules expected in the second half of 2026.
FDA meeting minutes say the existing data package appears sufficient for a BLA seeking accelerated approval; approval will be a matter of review.
Anaphylaxis occurred in 10 of 43 patients in the open label study, 9 of whom had prior exposure to nomlabofusp.
At 1 year, 100% (9/9) of participants had skin FXN levels above 50% of healthy volunteer mean; first patient dosing in a global Phase 3 study is expected in Q3 2026.
Verizon signed a transaction agreement on June 28, 2026 with BT Group and NewCo to combine its international wireline connectivity and managed network services business with BT's equivalent business, with each company holding 50% of NewCo. Verizon will also make a $625 million cash payment to NewCo, which will pass it to BT, and it expects a second-quarter 2026 estimated loss of $700 million to $800 million, plus severance and asset charges, that will weigh on reported results.
Transaction agreement signed June 28, 2026; closing is subject to customary regulatory approvals and closing conditions.
Verizon to pay $625 million in cash to NewCo; the value of each contributed business is subject to adjustment for cash, net working capital and indebtedness at closing.
Expected second-quarter 2026 estimated loss of $700 million to $800 million from classifying the Verizon Contributed Business as held for sale.
Severance charge of $350 million to $450 million and asset rationalization charges of $200 million to $300 million expected in the second quarter of 2026.
On June 27, 2026, Korn Ferry agreed to acquire AMS, a talent and consulting firm, for about £850 million (about $1.1 billion), with about $881 million in cash and about $255 million in Korn Ferry common stock. Closing requires regulatory approvals and is expected in the fiscal quarter ending October 30, 2026. Shareholders will see new shares issued and cash funded partly by revolver borrowings, and the company expects the deal to be immediately accretive to earnings per share in the first full year after adjusting for restructuring, integration and transaction costs.
Total price is about £850 million (about $1.1 billion): about $881 million in cash and about $255 million in Korn Ferry shares.
Cash funding is about $300 million from cash on hand and about $581 million from borrowings under the existing revolver.
AMS has about $650 million of run-rate fee revenue and $100 million of Adjusted EBITDA, according to the press release.
Closing requires HSR waiting period expiry and UK and German approvals, and may be terminated if conditions are not met within 180 days of signing.
On June 24, 2026, Allegiant Travel Company issued $650 million of 7.125% senior secured notes due July 1, 2031, and used part of the proceeds to buy $377.5 million of its 7.25% notes due 2027 tendered in a tender offer. The new notes are secured by substantially all company and guarantor assets except aircraft, aircraft engines and real property, and the company must keep at least $300.0 million of liquidity at each quarter end. Shareholders should note the added secured debt and the restrictive terms, while the filing does not give total debt or cash balances.
$650.0 million of 7.125% notes issued June 24, 2026, maturing July 1, 2031, with cash interest due January 1 and July 1 starting January 1, 2027
$377,534,000 of 7.25% notes due 2027 purchased on June 24, 2026, at total consideration of $1,005.00 per $1,000 principal; $25,465,000 remain and are expected to be redeemed in third quarter 2026
Notes are secured by substantially all assets excluding aircraft, aircraft engines and real property; a $300.0 million minimum liquidity covenant applies, with 2.0% additional interest if breached
Existing 2027 notes indenture amended to remove most restrictive covenants and cut the redemption notice period from 30 days to 3 business days
The FDA approved Viridian Therapeutics' Lumvoa (veligrotug-vvze) for thyroid eye disease regardless of disease activity or duration, and the company plans to launch it immediately. The approval is Viridian's first FDA-approved product and first commercial product, a milestone that moves the company from development toward sales.
FDA approval announced June 26, 2026; Lumvoa is the first TED treatment with labeling covering both active and chronic TED
Launch planned immediately; physicians can prescribe Lumvoa tomorrow, per the press release
Lumvoa is given as five intravenous infusions over 12 weeks; infusion reactions reported in about 9% of patients
Conference call and webcast scheduled Monday, June 29, 2026 at 8:00 a.m. ET
Phibro Animal Health said Daniel (Dani) Bendheim will become Chief Executive Officer and President effective July 1, 2026, under a new employment agreement with a $850,000 base salary. He also received a grant of 300,000 performance-based restricted stock units that vest only if the company's 90-day average stock price reaches $70 to $100 by June 30, 2031.
Bendheim's base salary is $850,000 annually, with a target bonus of 50% of base salary.
The 300,000 RSUs vest in 25% increments tied to a 90-day average stock price from $70 to $100 or above, with no vesting below $70.
Severance includes six months of base salary on death or disability and up to 18 months of company-subsidized COBRA coverage on termination without Cause or resignation.
Applied Digital's subsidiary APLD Intermediate HoldCo entered into an incremental agreement that raises the revolving credit commitments under its May 29, 2026 credit agreement to $430.0 million, maturing May 28, 2029. The company also amended its Preferred Equity Purchase Agreement to lift the Series G Convertible Preferred Stock commitment from $1.59 billion to $2.0 billion, adding capacity for future equity issuance to investors.
Secured revolving credit facility increased to $430.0 million, maturing May 28, 2029, with up to $120.0 million more available for a total of $550.0 million
Credit facility priced at Term SOFR plus 2.25% or base rate plus 1.25%, guaranteed by the company and restricted subsidiaries
PEPA Series G Convertible Preferred Stock commitment raised from $1,590,000,000 to $2,000,000,000 under the Sixth Amendment dated June 26, 2026
Fortrea appointed Jason Knoblauch as chief financial officer, effective July 6, 2026, succeeding Jill McConnell, who steps down on that date but will stay with the company for a transition period. The company said the change does not reflect any disagreement with Ms. McConnell over financial reporting, internal controls, or auditing. Fortrea also reiterated its full-year 2026 guidance, which it did not change.
Jason Knoblauch, 45, becomes CFO effective July 6, 2026; he previously was CFO at Clario, from August 2023 to June 2026.
Offer letter dated June 22, 2026 sets a $570,000 base salary, an 85% target bonus, and a $1,250,000 cash inducement paid $500,000 at start and $750,000 after one year.
Planned inducement equity of about $2,300,000 in RSUs and $1,700,000 in PSUs, anticipated in September 2026, capped at 400,000 shares combined.
2026 guidance reiterated: revenues of $2,550 million to $2,650 million and adjusted EBITDA of $190 million to $220 million.
Bristow Group agreed on June 23, 2026 to buy Berry Aviation, a special missions and government aviation provider, for $105 million in cash, subject to adjustments. The company also said it is pursuing a sale of its Norway offshore energy services business, and that the Berry deal would be neutral to its 2025 EBITDA on a pro forma basis with that exit.
Purchase price is $105 million in cash, subject to adjustment for working capital, cash, indebtedness and transaction expenses
Berry Aviation had 2025 total revenues of approximately $108 million and 2025 EBITDA of approximately $12 million, per the investor slides
Closing is expected in the third quarter of 2026 per the press release; the 8-K says the second half of 2026
Bristow intends to fund the deal with cash on hand; the Norway sale timing and structure remain subject to market conditions
Goodyear said Chief Financial Officer Christina Zamarro will step down effective June 30, 2026 and leave the company on July 10 to pursue another opportunity. Scott Deakin, 60, a former CFO of Gypsum Management & Supply, Inc., will serve as interim Executive Vice President and CFO from July 1 while the company searches for a permanent successor. The filing states that her departure is not related to the company's financial or operating results or to any disagreements over accounting or reporting.
Christina Zamarro steps down as EVP and CFO effective June 30, 2026, and leaves the company July 10, 2026.
Scott Deakin, 60, becomes interim EVP and CFO effective July 1, 2026, and will be the principal financial officer until a permanent CFO is appointed.
Deakin will receive a salary of $30,000 per week, a bonus of $5,000 per week based on weeks worked, and restricted stock units with a $500,000 grant date value.
Deakin was CFO of Gypsum Management & Supply, Inc. from 2019 to 2026; the company is conducting a comprehensive search for a permanent CFO.
H.B. Fuller and the board of Advanced Medical Solutions Group plc (AMS) agreed terms on a recommended cash offer, to be implemented through a UK court-sanctioned scheme of arrangement. The company has arranged bridge credit agreements of up to $2,086,713,188 (secured) and $917,000,000 (unsecured) to fund the deal and refinance debt, and expects completion by the end of calendar 2026, which would add new borrowings for shareholders to weigh against the strategic growth case.
AMS shareholders will receive 285 pence in cash per AMS share; the press release cites a total enterprise value of £715 million.
Secured Bridge Credit Agreement of up to $2,086,713,188 and Unsecured Bridge Credit Agreement of up to $917,000,000, both with Goldman Sachs Bank USA; loans would mature 364 days after closing.
Completion is expected by the end of calendar 2026, subject to AMS shareholder approval, High Court sanction, regulatory approvals, and a Long-Stop Date of June 25, 2027.
Company expects approximately $55 million in combined run-rate revenue and cost synergies by 2031.
Atara Biotherapeutics said its chief accounting officer, Yanina Grant-Huerta, will leave effective July 17, 2026. The board appointed Kevin G. Sarney, a consultant from Charles River CFO, Inc., as interim chief financial officer effective June 26, 2026, and he will also serve as principal accounting officer. The change in its top finance roles is notable for shareholders because it comes through a consulting arrangement rather than a permanent hire.
Yanina Grant-Huerta, Chief Accounting Officer, was notified June 22, 2026 that her employment ends effective July 17, 2026.
Kevin G. Sarney appointed interim chief financial officer effective June 26, 2026, serving as principal financial and principal accounting officer.
Sarney's services are provided under a consulting agreement with Charles River CFO, Inc.; the Company pays an agreed hourly rate and Sarney receives no direct compensation from the Company.
The consulting agreement can be terminated by either party on 30 days written notice.
Ark Restaurants said a New York court on June 18, 2026 granted it summary judgment on its breach of contract claim over the Bryant Park Grill lease and the related right of first lease for the Bryant Park Café, with money damages to be set at a later trial. The court also ruled against the company on ejectment and use and occupancy claims for the Café and The Porch, and the company says it will appeal the adverse portions, which would automatically stay eviction while the appeal is pending. The company says the dispute has had and is expected to continue to have a material adverse impact on its business and results.
June 18, 2026: court granted Ark summary judgment on breach of contract for the Bryant Park Grill lease and related right of first lease for the Bryant Park Café
Court did not grant specific performance and did not preclude the Landlord's ejectment claim; damages for the Grill to be determined at a future trial
Court ruled for the Landlord on ejectment, use and occupancy, and breach of contract for the Café and The Porch; the Landlord may seek use and occupancy damages at trial
Company intends to file a Notice of Appeal, which would stay eviction pending appeal; the court will set the amount of the required undertaking
REalloys Inc. closed a private placement on June 26, 2026, selling 7,017,540 shares of common stock at $14.25 per share for gross proceeds of approximately $100 million, before placement agent fees and offering expenses. The company will use the net proceeds for working capital and general corporate purposes, and it has agreed to register the resale of the shares, which adds new shares that could dilute existing shareholders.
Sold 7,017,540 shares of common stock at $14.25 per share, for gross proceeds of approximately $100 million
Closed on June 26, 2026, after the purchase agreement was signed on June 24, 2026
Clear Street LLC was the sole placement agent; net proceeds will go to working capital and general corporate purposes
Company agreed to file a registration statement to register the resale of the shares
Bio-Techne entered a merger agreement under which Merck KGaA's subsidiary will merge into the company, leaving Bio-Techne as a wholly-owned Merck KGaA subsidiary. Each share will convert into the right to receive $73.00 in cash, and the board has recommended that shareholders approve the deal.
Merger consideration: $73.00 in cash per share of common stock, less any required tax withholdings
Buyer: Merck KGaA, Darmstadt, Germany, through its subsidiary EMD Holdings NewCo, Inc.
Closing requires majority shareholder approval, expiration of the Hart-Scott-Rodino waiting period and other required approvals, and no Burdensome Condition
Robinhood completed a $2.2 billion private offering of 0.00% convertible senior notes maturing October 1, 2029, including a $200 million option the initial purchasers exercised in full. The company used about $290 million of the net proceeds to repurchase 2.743 million Class A shares and $123.2 million to buy capped calls meant to offset dilution, so shareholders face potential dilution only above the cap price.
$2.2 billion aggregate principal of 0.00% convertible senior notes due October 1, 2029, closed June 25, 2026; net proceeds about $2.169 billion
Initial conversion price about $174.42 per share, a premium of about 65% to the June 22, 2026 closing price
About $290 million used to repurchase 2.743 million Class A shares; $123.2 million used for capped calls with a cap price of about $237.85 per share
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.